Home > Boards > US Listed > Biotechs >

Algernon Pharmaceuticals Inc. (AGNPF)

AGNPF RSS Feed
Add AGNPF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, DannyDanboy, GVX808, bettingonbayst, SoulTsunami
Search This Board: 
Last Post: 9/19/2020 4:11:25 PM - Followers: 187 - Board type: Free - Posts Today: 0

Algernon Pharmaceuticals is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF).

 
The Algernon drug development program was the brainchild of Dr. Mark Williams, the Company’s CSO, whose innovative approach to drug discovery was developed over many years as senior scientist in the drug development industry. The company and its business model is highly capital efficient and strives to deliver maximum shareholder value.
 
Algernon’s unique approach to drug discovery is based on the concept of drug repurposing. Drug repurposing is the process of discovering new therapeutic uses for existing drugs. Repurposing offers several benefits over traditional drug development including a reduction in investment and risk, shorter research periods and a longer active patent life.


Drug Repurposing Strategy

A Drug Repurposing Strategy Can Save up to 8 years of Pre-Clinical Research And Multi Millions in R&D Costs.

 The Algernon business model is to take safe approved genericized drugs, screen them in globally accepted animal models for new diseases, file new intellectual property rights and then efficiently move them into off label phase II trials in the country where they were originally approved. Once a signal is established in a human trial, the company will begin to advance the repurposed drug through a US FDA registration.

11 drug candidates were initially screened by the Company in globally accepted in vivo animal models for 4 new disease areas:

Non-alcoholic Steatohepatitis (NASH)
Chronic Kidney Disease (“CKD”)
Inflammatory Bowel Disease (IBD)
Idiopathic Pulmonary Fibrosis(IPF)

Initial studies showed that a number of the 11 drug candidates either performed equal to or better than the positive controls in each of the animal studies. Subsequent in vivo studies have confirmed their efficacy.

All Algernon research studies were conducted by 3rd party contract research organizations. The studies were well designed with proper positive controls, using the currently accepted gold standard for treatment in the disease being screened.



Targeted Diseases

Algernon Pharmaceuticals has developed strong pre-clinical data that supports the advancement of 4 of its leading drug candidates into phase II trials in the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF).
 
Non–alcoholic Steatohepatitis

 

CKD

Chronic Kidney Disease

 

IBD

Inflammatory Bowel Disease

 

IPF

Idiopathic Pulmonary Fibrosis

 
Ifenprodil: The Specialized Drug Treating Coronavirus
 

Christopher J. Moreau, Chief Executive Officer
Mark Williams PhD MBA, Chief Science Officer

General Inquiriesinfo@algernonpharmaceuticals.com
Head Office: Suite 915 – 700 West Pender Street Vancouver, BC, Canada V6C 1G
Shares Outstanding:
135,732,455
  Fully Diluted: 190.0M+


  
algernonpharmaceuticals.com

 

COVID-19 UPDATE:

Algernon Pharmaceuticals receives ok from South Korea for phase two study of Ifenprodil
 
 
AGNPF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AGNPF News: Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19 06/04/2020 12:41:39 PM
AGNPF News: Small Company Offering and Sale of Securities Without Registration (d) 05/27/2020 03:14:43 PM
AGNPF News: Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard 04/13/2020 09:44:01 AM
PostSubject
#11588  Sticky Note Algernon Announces Data and Safety Monitoring Board Recommends shell3 09/16/20 08:04:30 AM
#11622   Should be only the Rights of Ifenprodil for shell3 09/19/20 04:11:25 PM
#11621   Anyone think there could be a potential buy fishonit 09/19/20 03:41:13 PM
#11620   So a long term strategy I would follow.. Get McMagyar 09/19/20 03:34:55 PM
#11619   Some have stated that a MC of $1B tcm55 09/19/20 03:27:42 PM
#11618   I like the $2 billion MC.... McMagyar 09/19/20 03:02:36 PM
#11617   Nice thought Smoki. I've been discussing buyout's at tcm55 09/19/20 02:59:25 PM
#11615   Call the warrants McMagyar 09/18/20 10:50:23 PM
#11614   Buying opportunities Lowersioux5 09/18/20 06:56:13 PM
#11613   I don't understand. Much more buy and the casios01 09/18/20 03:36:34 PM
#11612   Good point. Fox Business would be much better! GVX808 09/18/20 10:48:31 AM
#11611   Great Finds! Flyerpf64 09/18/20 06:42:44 AM
#11610   Great find! Thanks for sharing. GVX808 09/17/20 11:43:41 PM
#11609   Thoughts for the morning... 12.50 GLTA smoki 09/17/20 06:37:06 PM
#11608   Keep’em coming https://m.youtube.com/watch?v=XrtnTXB54b8 smoki 09/17/20 06:23:12 PM
#11607   Where there's smoke, there's fire.. Smoki is on fire! bettingonbayst 09/17/20 05:38:17 PM
#11606   Here’s another one GL!!!https://m.youtube.com/watch?v=7iM8T6wcY3U smoki 09/17/20 05:10:34 PM
#11605   Thx for the re-post Shell!! smoki 09/17/20 05:05:18 PM
#11604   Nice Find smoki shell3 09/17/20 04:46:07 PM
#11603   Here we go go.. https://m.youtube.com/watch?v=DHpByMc3hsY smoki 09/17/20 04:34:33 PM
#11602   The arrow in this chart is not indicative bettingonbayst 09/17/20 04:31:21 PM
#11601   Looks like my technical analysis is on point bettingonbayst 09/17/20 04:18:42 PM
#11600   Move the decimal to the right a couple smoki 09/16/20 09:27:44 PM
#11599   So we know it's safe and doctors are EagleD 09/16/20 08:45:37 PM
#11598   Algernon Announces Data and Safety Monitoring Board Recommends AllGold818 09/16/20 07:23:59 PM
#11597   do u know what we got here????.....30 dolla jaggerxj6 09/16/20 02:36:58 PM
#11596   Great news yesterday and today, looking great here. bettingonbayst 09/16/20 02:02:12 PM
#11595   https://seekingalpha.com/news/3614672-algernon-pharma-to-continue-covidminu GVX808 09/16/20 02:01:05 PM
#11594   Starting to look and sound encouraging! $AGNPF gonna $BLO !!! GVX808 09/16/20 01:39:29 PM
#11593   All Aboard! Chooo Choooooo hahahaha lets see GMoney74 09/16/20 01:35:33 PM
#11592   No convencing anyone to buy now ... take smoki 09/16/20 01:10:38 PM
#11591   Probably within a week. Maybe even later EagleD 09/16/20 08:15:32 AM
#11590   We have to be getting close shell3 09/16/20 08:12:47 AM
#11589   So we have confirmed safety, and news reports EagleD 09/16/20 08:09:55 AM
#11588   Algernon Announces Data and Safety Monitoring Board Recommends shell3 09/16/20 08:04:30 AM
#11587   Reporting out of Ohio indicates ifenprodil is working EagleD 09/16/20 07:00:07 AM
#11586   Algernon will be All over the Map this smoki 09/16/20 01:06:30 AM
#11584   Hole Mole’ Best New’s Ever!! Algernon to Marzzz!! smoki 09/15/20 09:03:33 PM
#11583   50% is very sad at this stage. Jgregsr 09/15/20 07:26:30 PM
#11582   Novatech's CEO on Algernon drt1111 09/15/20 07:24:57 PM
#11581   New Local news coverage drt1111 09/15/20 07:09:06 PM
#11580   Probably later this week or early next week EagleD 09/14/20 06:34:53 PM
#11579   Long term lung damage ... could be another smoki 09/14/20 03:45:30 PM
#11578   XBI up huge this morning. Hopefully we see EagleD 09/14/20 07:26:09 AM
#11575   As Wildfires Rage: Current Cities With The Worst AMG 09/12/20 12:58:55 AM
#11574   No buyers. casios01 09/11/20 12:11:27 PM
#11573   September 11 attacks AMG 09/11/20 12:47:10 AM
#11572   I'd imagine there's something along those lines to AMG 09/11/20 12:10:06 AM
#11571   Their all different Videos and geared for one shell3 09/10/20 11:59:20 PM
#11570   shell3, you have to also take into account AMG 09/10/20 11:52:52 PM
#11569   6 Days Ago — 21 Views shell3 09/10/20 11:48:39 PM
PostSubject
Consent Preferences